한글목차

세계의 치은농양 치료제 시장은 연고, 구강청결제, 치약 등의 분야에서 성장 기회를 배경으로 미래가 기대되는 시장입니다. 2025-2031년 세계 치은농양 치료제 시장은 연평균 8.5%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예측됩니다. 이 시장의 주요 성장 요인은 구강 위생과 치은 농양 예방에 대한 인식이 높아지고, 편리하고 효과적인 구강 관리 치료에 대한 수요가 증가하고 있기 때문입니다.

• Lucintel의 예측에 따르면 유형별로는 클로르헥시딘이 예측 기간 중 가장 높은 성장률을 보일 것으로 예측됩니다.
• 용도별로는 연고가 가장 높은 성장률을 보일 것으로 예측됩니다.
• 지역별로는 아시아태평양(APAC)이 예측 기간 중 가장 높은 성장률을 보일 것으로 예측됩니다.

치은농양 치료제 시장의 새로운 동향

세계 치은농양 치료제 시장은 기술 발전, 소비자 행동의 변화, 인식의 변화로 인해 변화의 시기를 맞이하고 있습니다. 이러한 추세는 치은농양 환자들에게 보다 효과적인 치료, 접근성 향상, 건강관리 결과 개선으로 이어지고 있습니다. 시장을 재편하는 5가지 새로운 동향을 소개한다:

• 표적 항생제 사용: 표적 항생제는 치은농양의 표준 치료법이 되고 있습니다. 이러한 항생제는 감염을 유발하는 특정 박테리아에 더 효과적이며, 광범위 항생제의 필요성을 줄여줍니다. 이러한 추세는 항생제 내성 예방에 기여하고, 환자의 더 나은 치료 결과를 보장합니다.
• 원격의료와 원격진단: 원격의료는 특히 지방이나 의료취약지역에서 치은농양의 진단과 치료에 더 큰 역할을 하고 있습니다. 치과 전문가와의 원격 상담을 통해 환자는 대면 진료 없이도 적시에 진료를 받을 수 있으며, 치료 접근성이 향상되고 있습니다.
• 최소침습적 치료: 레이저 치료와 첨단 배농술을 포함한 최소침습적 치료는 점점 더 널리 보급되고 있습니다. 이러한 방법은 환자의 불편함을 줄이고 회복 기간을 단축시키며 치료의 정확도를 높입니다. 이러한 추세에 따라 치은농양 치료는 더욱 효율적이고 환자 친화적으로 변화하고 있습니다.
• 약초요법과 자연요법: 치은농양에 대한 약초요법과 자연요법에 대한 관심이 높아지고 있으며, 특히 중국, 인도 등의 지역에서 두드러지게 나타나고 있습니다. 이러한 대체요법은 기존 치료와 함께 구강 건강에 대한 종합적인 접근 방식을 제공합니다. 자연적 해결책을 원하는 소비자의 니즈에 부응하는 것입니다.
• 예방관리 및 교육: 예방관리 노력이 확대되고 있으며, 좋은 구강위생 유지의 중요성에 대한 일반 대중의 인식 개선 활동이 강화되고 있습니다. 이러한 추세는 조기 개입과 더 나은 장기 치료를 촉진하여 치은 농양 발생률을 낮추고 있습니다.

치은농양 치료제 시장의 새로운 동향은 보다 효과적이고 환자 중심의 치료를 강조하며 치료 제공 방식을 변화시키고 있습니다. 이러한 혁신은 환자의 치료 결과를 개선하고, 접근성을 높이며, 특히 개발도상국에서 시장 성장을 위한 길을 열어주고 있습니다.

치은농양 치료제 시장의 최근 동향

세계 치은농양 치료제 시장의 최근 동향은 보다 진보적이고 환자 중심의 치료법으로의 전환을 반영하고 있습니다. 신제품, 기술 발전, 규제적 지원으로 시장은 계속 진화하고 있습니다. 이 변화를 형성하는 5가지 주요 발전은 다음과 같습니다.

• 신규 항생제 도입: 제약사들은 치은농양 원인균에 특화된 신규 항생제를 개발 중입니다. 이러한 항생제들은 효과의 향상과 부작용의 감소를 실현하여 환자의 치료 결과를 향상시킵니다.
• 레이저 치료의 대중화: 치은농양에 대한 레이저 치료는 전 세계 치과에서 점점 더 보편화되고 있습니다. 이러한 시술은 기존의 수술적 방법의 필요성을 줄이고, 환자의 불편함을 최소화하면서 치료의 정확성과 속도를 향상시킵니다.
• 구강 건강 관련 정부 프로그램: 여러 정부에서 치과 위생을 개선하고 치주질환의 유병률을 낮추기 위한 프로그램을 시작했습니다. 이러한 노력으로 치은농양 치료에 대한 인식과 수요가 증가하고 있습니다.
• 디지털 헬스 플랫폼의 성장: 원격의료 서비스, 모바일 앱 등 디지털 헬스 플랫폼은 치은농양의 원격 진료를 촉진하고 있습니다. 이러한 플랫폼을 통해 환자들은 치과에 직접 방문하지 않고도 적시에 진료를 받고 치료 조언을 받을 수 있습니다.
• 저렴한 치료 옵션에 대한 관심 증가: 특히 인도, 중국 등 신흥 시장에서 저렴한 치료 옵션에 대한 수요가 증가하고 있습니다. 제약사들은 이에 대응하여 비용 효율적인 솔루션을 제공함으로써 보다 많은 사람들이 치은농양 치료제를 이용할 수 있도록 하고 있습니다.

이러한 주요 발전은 새로운 치료 옵션, 개선된 환자 치료 모델, 정부 지원 강화로 인해 치은농양 치료제 시장이 진화하고 있음을 보여줍니다. 이러한 변화로 인해 특히 치주질환이 심각한 지역에서 치료의 접근성, 효과성, 경제성이 향상되고 있습니다.

목차

제1장 개요

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 치은농양 치료제 시장 : 유형별

• 매력 분석 : 유형별
• 염산염
• 클로르헥시딘
• 요오드 글리세롤

제5장 세계의 치은농양 치료제 시장 : 용도별

• 매력 분석 : 용도별
• 연고
• 구강청결제
• 치약
• 기타

제6장 지역 분석

제7장 북미의 치은농양 치료제 시장

• 북미의 치은농양 치료제 시장 : 유형별
• 북미의 치은농양 치료제 시장 : 용도별
• 미국의 치은농양 치료제 시장
• 멕시코의 치은농양 치료제 시장
• 캐나다의 치은농양 치료제 시장

제8장 유럽의 치은농양 치료제 시장

• 유럽의 치은농양 치료제 시장 : 유형별
• 유럽의 치은농양 치료제 시장 : 용도별
• 독일의 치은농양 치료제 시장
• 프랑스의 치은농양 치료제 시장
• 스페인의 치은농양 치료제 시장
• 이탈리아의 치은농양 치료제 시장
• 영국의 치은농양 치료제 시장

제9장 아시아태평양의 치은농양 치료제 시장

• 아시아태평양의 치은농양 치료제 시장 : 유형별
• 아시아태평양의 치은농양 치료제 시장 : 용도별
• 일본의 치은농양 치료제 시장
• 인도의 치은농양 치료제 시장
• 중국의 치은농양 치료제 시장
• 한국의 치은농양 치료제 시장
• 인도네시아의 치은농양 치료제 시장

제10장 기타 지역(ROW)의 치은농양 치료제 시장

• ROW의 치은농양 치료제 시장 : 유형별
• ROW의 치은농양 치료제 시장 : 용도별
• 중동의 치은농양 치료제 시장
• 남미의 치은농양 치료제 시장
• 아프리카의 치은농양 치료제 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
• 세계의 치은농양 치료제 시장의 새로운 동향
• 전략 분석

제13장 밸류체인에서 주요 기업의 개요

• 경쟁 분석
• OraPharma Inc
• Sunstar Group
• Hainan Jianke Pharmaceutical
• South China Pharmaceutical
• Jiangsu Chenpai Pharmaceutical
• Lion Corporation
• GlaxoSmithKline

제14장 부록

영문목차

The future of the global gingival abscess medicine market looks promising with opportunities in the ointment, mouthwash, toothpaste, and others markets. The global gingival abscess medicine market is expected to grow with a CAGR of 8.5% from 2025 to 2031. The major drivers for this market are rising awareness of oral hygiene and gingival abscess prevention. and increasing demand for convenient and effective oral care treatments..

• Lucintel forecasts that, within the type category, chlorhexidine is expected to witness the highest growth over the forecast period.
• Within the application category, ointment is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Gingival Abscess Medicine Market

The global gingival abscess medicine market is undergoing a shift due to technological advancements, evolving consumer behavior, and increased awareness. These trends are leading to more effective treatments, greater accessibility, and improved healthcare outcomes for gingival abscess patients. Below are five emerging trends that are reshaping the market:

• Use of Targeted Antibiotics: Targeted antibiotics are becoming the standard treatment for gingival abscesses. These antibiotics are more effective against the specific bacteria causing the infection, reducing the need for broad-spectrum antibiotics. This trend helps in preventing antibiotic resistance, ensuring better patient outcomes.
• Telemedicine and Remote Diagnostics: Telemedicine is playing a larger role in diagnosing and treating gingival abscesses, especially in rural and underserved areas. Remote consultations with dental professionals allow patients to receive timely care without the need for in-person visits, improving accessibility to treatment.
• Minimally Invasive Treatments: Minimally invasive treatments, including laser therapies and advanced drainage techniques, are gaining popularity. These methods reduce patient discomfort, shorten recovery times, and improve the precision of treatments. This trend is helping make gingival abscess treatments more efficient and patient-friendly.
• Herbal and Natural Remedies: There is a growing interest in herbal and natural remedies for gingival abscesses, particularly in regions like China and India. These alternatives are being used alongside conventional treatments to provide a holistic approach to oral health, appealing to consumers seeking natural solutions.
• Preventive Care and Education: Preventive care initiatives are expanding, with an increased focus on educating the public about the importance of maintaining good oral hygiene. This trend is reducing the incidence of gingival abscesses by encouraging early intervention and better long-term care.

The emerging trends in the gingival abscess medicine market are transforming the way treatments are delivered, with an emphasis on more effective, patient-centric approaches. These innovations are improving patient outcomes, enhancing accessibility, and paving the way for further growth in the market, particularly in developing regions.

Recent Developments in the Gingival Abscess Medicine Market

Recent developments in the global gingival abscess medicine market reflect the shift towards more advanced and patient-focused treatments. With new products, technological advancements, and regulatory support, the market is evolving. Below are five key developments that are shaping this transformation:

• Introduction of Novel Antibiotics: Pharmaceutical companies are developing new antibiotics that specifically target the bacteria responsible for gingival abscesses. These antibiotics offer improved effectiveness and fewer side effects, providing better outcomes for patients.
• Laser-Assisted Treatments: Laser-assisted treatments for gingival abscesses are becoming more common in dental practices worldwide. These procedures reduce the need for traditional surgical methods and minimize patient discomfort while improving the accuracy and speed of treatment.
• Government Programs for Oral Health: Several governments are launching programs aimed at improving dental hygiene and reducing the prevalence of gingival diseases. These initiatives are leading to increased awareness and demand for treatments for gingival abscesses.
• Growth of Digital Health Platforms: Digital health platforms, such as telemedicine services and mobile apps, are facilitating remote consultations for gingival abscesses. These platforms allow patients to seek timely care and receive treatment advice without needing to visit a dentist in person.
• Increased Focus on Affordable Treatment Options: The demand for affordable treatments is growing, particularly in emerging markets like India and China. Pharmaceutical companies are responding by offering cost-effective solutions, making gingival abscess medicines accessible to a broader population.

These key developments demonstrate how the gingival abscess medicine market is evolving with new treatment options, improved patient care models, and increased government support. These changes are making treatments more accessible, effective, and affordable, especially in regions where gum disease is a growing concern.

Strategic Growth Opportunities in the Gingival Abscess Medicine Market

The gingival abscess medicine market offers several strategic growth opportunities across key applications. As the market expands, businesses can capitalize on these opportunities to enhance their offerings and reach a wider customer base. Below are five key growth opportunities by application:

• Preventive Dental Care: Preventive care is a growing focus in the gingival abscess market. By promoting oral hygiene education and the use of preventive treatments, companies can reduce the incidence of gingival abscesses and drive demand for early-stage solutions, which help maintain long-term oral health.
• Telehealth Solutions: As telemedicine continues to gain traction, companies can invest in digital health solutions that offer remote diagnostics and consultations for gingival abscesses. This opportunity can expand the reach of treatments, especially in remote areas where access to dental professionals is limited.
• Combination Therapies: The development of combination therapies, which include antibiotics, anti-inflammatory drugs, and localized treatments, offers a significant growth opportunity. These therapies provide more comprehensive care, improving treatment outcomes and patient satisfaction.
• Affordable Treatment Options for Emerging Markets: Developing affordable treatment options tailored to emerging markets like India and China can address the increasing demand for gingival abscess medications. Companies can target these regions with cost-effective solutions, expanding their market share and reaching underserved populations.
• Laser and Minimally Invasive Procedures: Investing in minimally invasive procedures, such as laser treatments, can enhance patient experience and drive growth in the market. These methods reduce recovery time and improve treatment accuracy, making them an attractive option for both patients and dental professionals.

These strategic growth opportunities highlight the diverse potential for businesses in the gingival abscess medicine market. By capitalizing on emerging trends and focusing on underserved regions, companies can expand their market presence and improve patient outcomes.

Gingival Abscess Medicine Market Driver and Challenges

The gingival abscess medicine market is influenced by a combination of drivers and challenges that impact its growth and development. The following factors play a significant role in shaping the market.

The factors responsible for driving the Gingival Abscess Medicine market include:

1. Advancements in Medical Treatments: The development of more effective and targeted treatments for gingival abscesses is driving market growth. New antibiotics, laser treatments, and combination therapies are improving patient outcomes and making treatment more efficient.

2. Rising Awareness of Oral Health: Increased public awareness about the importance of oral hygiene and the prevalence of gum diseases is driving demand for gingival abscess treatments. Public health campaigns and educational programs are contributing to the growth of the market.

3. Government Support for Dental Health: Government initiatives aimed at improving oral health and reducing the prevalence of gingival diseases are driving market expansion. These initiatives include funding for dental health programs and subsidies for treatments in certain regions.

4. Technological Advancements in Diagnosis and Treatment: The integration of advanced diagnostic tools and treatment methods, such as lasers and digital platforms, is driving growth in the gingival abscess medicine market. These innovations improve the accuracy and efficiency of treatments, attracting more patients to seek care.

5. Aging Population: As the global population ages, the incidence of oral health problems, including gingival abscesses, is rising. This demographic shift is increasing the demand for effective and accessible treatments for gum diseases.

Challenges in the Gingival Abscess Medicine market are:

1. High Cost of Treatments: The cost of advanced treatments, such as laser therapy and specialized antibiotics, remains a significant barrier to widespread adoption. This challenge is particularly pronounced in developing regions, where affordable options are needed.

2. Lack of Awareness in Rural Areas: Despite rising awareness in urban regions, rural areas still face challenges in accessing information about gingival abscesses and proper oral care. Limited access to dental professionals exacerbates this issue.

3. Regulatory Barriers: Regulatory hurdles and inconsistent regulations across different regions can slow the approval and availability of new treatments. Companies may face challenges in obtaining approvals for new drugs or technologies, delaying market access.

The gingival abscess medicine market is driven by advancements in treatment options, rising awareness of oral health, and government initiatives. However, challenges such as high treatment costs, lack of awareness in rural areas, and regulatory barriers remain. Addressing these issues will be crucial for continued growth and improving global access to gingival abscess treatments.

List of Gingival Abscess Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gingival abscess medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gingival abscess medicine companies profiled in this report include-

• OraPharma Inc
• Sunstar Group
• Hainan Jianke Pharmaceutical
• South China Pharmaceutical
• Jiangsu Chenpai Pharmaceutical
• Lion Corporation
• GlaxoSmithKline

Gingival Abscess Medicine Market by Segment

The study includes a forecast for the global gingival abscess medicine market by type, application, and region.

Gingival Abscess Medicine Market by Type [Value from 2019 to 2031]:

• Hydrochloride
• Chlorhexidine
• Iodine Glycerol

Gingival Abscess Medicine Market by Application [Value from 2019 to 2031]:

• Ointment
• Mouthwash
• Toothpaste
• Others

Gingival Abscess Medicine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Gingival Abscess Medicine Market

The global gingival abscess medicine market is evolving as advancements in diagnostics, treatment methods, and pharmaceutical solutions are addressing the increasing prevalence of gum infections. Countries like the United States, China, Germany, India, and Japan are experiencing significant developments in this area. These changes are driven by technological innovations in treatment protocols, growing awareness about oral health, and regulatory improvements, ultimately reshaping the market across key regions.

• United States: In the United States, the gingival abscess medicine market has witnessed significant growth due to increased awareness of oral hygiene and the rise in gum-related diseases. The market is seeing the introduction of advanced antibiotics, anti-inflammatory drugs, and combination therapies. Digital tools such as telemedicine consultations are also facilitating easier diagnosis and treatment for gingival abscesses, leading to more accessible care. Pharmaceutical companies are focusing on expanding their product ranges, targeting both acute and chronic gingival abscess conditions.
• China: China's gingival abscess medicine market is growing rapidly, driven by increasing healthcare access and an aging population. With oral hygiene awareness rising in urban and rural areas, more people are seeking effective treatments for gingival abscesses. Chinese companies are introducing innovative formulations, including herbal-based medicines, in addition to conventional antibiotics. Government support for dental health initiatives, particularly in rural areas, is boosting demand for affordable treatments and preventive solutions for gingival conditions.
• Germany: Germany continues to lead in the development of advanced treatments for gingival abscesses, with a focus on research and innovation. Pharmaceutical companies in Germany are introducing new drugs that offer more targeted and effective treatments for gingival abscesses. Additionally, German dentists are adopting a more proactive approach to treatment, incorporating advanced diagnostic tools such as lasers and imaging technology. The government is also supporting dental health programs to reduce the incidence of gum diseases and improve early diagnosis.
• India: In India, the gingival abscess medicine market is expanding due to rising urbanization, greater access to healthcare, and increasing awareness of the importance of oral hygiene. Indian pharmaceutical companies are offering affordable, generic treatments for gingival abscesses, making them accessible to a wider population. The government's focus on improving dental health and hygiene, combined with the introduction of preventive solutions, is expected to drive future market growth.
• Japan: Japan's gingival abscess medicine market is characterized by a high level of awareness about oral health and preventive care. In recent years, Japan has seen a rise in the adoption of advanced treatment methods, including minimally invasive procedures and laser treatments. Japanese pharmaceutical companies are incorporating newer antibiotics and localized treatments for better efficacy. The aging population and increasing demand for preventive dental care are also contributing to market growth in the region.

Features of the Global Gingival Abscess Medicine Market

• Market Size Estimates: Gingival abscess medicine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Gingival abscess medicine market size by type, application, and region in terms of value ($B).
• Regional Analysis: Gingival abscess medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the gingival abscess medicine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gingival abscess medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the gingival abscess medicine market by type (hydrochloride, chlorhexidine, and iodine glycerol), application (ointment, mouthwash, toothpaste, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Gingival Abscess Medicine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Hydrochloride: Trends and Forecast (2019-2031)
• 4.4 Chlorhexidine: Trends and Forecast (2019-2031)
• 4.5 Iodine Glycerol: Trends and Forecast (2019-2031)

5. Global Gingival Abscess Medicine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Ointment: Trends and Forecast (2019-2031)
• 5.4 Mouthwash: Trends and Forecast (2019-2031)
• 5.5 Toothpaste: Trends and Forecast (2019-2031)
• 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Gingival Abscess Medicine Market by Region

7. North American Gingival Abscess Medicine Market

• 7.1 Overview
• 7.2 North American Gingival Abscess Medicine Market by type
• 7.3 North American Gingival Abscess Medicine Market by application
• 7.4 United States Gingival Abscess Medicine Market
• 7.5 Mexican Gingival Abscess Medicine Market
• 7.6 Canadian Gingival Abscess Medicine Market

8. European Gingival Abscess Medicine Market

• 8.1 Overview
• 8.2 European Gingival Abscess Medicine Market by type
• 8.3 European Gingival Abscess Medicine Market by application
• 8.4 German Gingival Abscess Medicine Market
• 8.5 French Gingival Abscess Medicine Market
• 8.6 Spanish Gingival Abscess Medicine Market
• 8.7 Italian Gingival Abscess Medicine Market
• 8.8 United Kingdom Gingival Abscess Medicine Market

9. APAC Gingival Abscess Medicine Market

• 9.1 Overview
• 9.2 APAC Gingival Abscess Medicine Market by type
• 9.3 APAC Gingival Abscess Medicine Market by application
• 9.4 Japanese Gingival Abscess Medicine Market
• 9.5 Indian Gingival Abscess Medicine Market
• 9.6 Chinese Gingival Abscess Medicine Market
• 9.7 South Korean Gingival Abscess Medicine Market
• 9.8 Indonesian Gingival Abscess Medicine Market

10. ROW Gingival Abscess Medicine Market

• 10.1 Overview
• 10.2 ROW Gingival Abscess Medicine Market by type
• 10.3 ROW Gingival Abscess Medicine Market by application
• 10.4 Middle Eastern Gingival Abscess Medicine Market
• 10.5 South American Gingival Abscess Medicine Market
• 10.6 African Gingival Abscess Medicine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Gingival Abscess Medicine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 OraPharma Inc
  • Company Overview
  • Gingival Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Sunstar Group
  • Company Overview
  • Gingival Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Hainan Jianke Pharmaceutical
  • Company Overview
  • Gingival Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 South China Pharmaceutical
  • Company Overview
  • Gingival Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Jiangsu Chenpai Pharmaceutical
  • Company Overview
  • Gingival Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Lion Corporation
  • Company Overview
  • Gingival Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 GlaxoSmithKline
  • Company Overview
  • Gingival Abscess Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us